ArticleBlood advances2023

Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.

Tomohiro Urata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.